Utilization frequency and patient-reported effectiveness of symptomatic therapies in post-COVID syndrome
The study was registered at the German Clinical Trials Register (DRKS-ID: DRKS00033621) on March 20, 2024.
Authors
- Johannes Krehbiel
- Jürgen Rech (ORCID: https://orcid.org/0000-0002-2569-2029)
- Eva Morawa (ORCID: https://orcid.org/0000-0002-2885-7503)
- Yeşim Erim (ORCID: https://orcid.org/0000-0002-8215-1798)
- Miriam Reuner
- Isabel Cecil Schäfer
- Regina Herold
- Brigitte Greiner
Institutions
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Universitätsklinikum Erlangen (DE)
- Comprehensive Cancer Center Erlangen (DE)
Publication Details
- Journal
- BMC Public Health
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1186/s12889-024-19951-3
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universitätsklinikum Erlangen